The store will not work correctly when cookies are disabled.
ID: ALA2397465
Max Phase: Preclinical
Molecular Formula: C12H9Cl2N3O
Molecular Weight: 282.13
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NCc1cccc(Cl)c1)c1cnc(Cl)cn1
Standard InChI: InChI=1S/C12H9Cl2N3O/c13-9-3-1-2-8(4-9)5-17-12(18)10-6-16-11(14)7-15-10/h1-4,6-7H,5H2,(H,17,18)
Standard InChI Key: ASOAPRDJWQEZHW-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 282.13 | Molecular Weight (Monoisotopic): 281.0123 | AlogP: 2.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.50 | CX Basic pKa: | CX LogP: 2.15 | CX LogD: 2.15 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.94 | Np Likeness Score: -1.91 |
References
1. Servusová B, Vobicková J, Paterová P, Kubíček V, Kuneš J, Doležal M, Doležal M, Zitko J.. (2013) Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides., 23 (12): [PMID:23659859] [10.1016/j.bmcl.2013.04.021] |